November 2024

An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease

The novel results have been presented at the Kidney Week 2024 Congress of the American Society of Nephrology, in San Diego, and have been published simultaneously in the prestigious journal Nature Medicine. In Spain, 40% of the population is overweight, 22% of the population is obese and 3 out of 10 patients with chronic kidney disease suffer from obesity.

An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease Read More »

According to a European survey, only 6 of every 10 Spanish houses are smoke-free

Seven out of ten homes in Europe are smoke-free, according to a major survey published today in ERJ Open Research.
In Romania, Bulgaria and Spain, more than four in ten homes allow smoking to take place, while England scored highest with more than eight in ten homes smoke-free.

According to a European survey, only 6 of every 10 Spanish houses are smoke-free Read More »

The second RegenBell Symposium on stem cells and regenerative medicine takes place

The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject. 11 conferences were presented, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

The second RegenBell Symposium on stem cells and regenerative medicine takes place Read More »

The Marató 3Cat finances three IDIBELL projects in sexual and reproductive health

Drs. Laia Alemany, Mireia Martín Satué, Jordi Guiu and Gabriel Capellá will carry out their research projects in sexual and reproductive health thanks to the funds raised by La Marató 2023.

The Marató 3Cat finances three IDIBELL projects in sexual and reproductive health Read More »

Researchers identify inflammatory markers related to the prognosis of breast cancer

A study by IDIBELL, ICO and IARC has linked the levels of certain inflammatory molecules with mortality in breast cancer patients.
The study, published in the British Journal of Cancer, included 1538 women from eight countries belonging to the EPIC cohort and diagnosed with breast cancer.

Researchers identify inflammatory markers related to the prognosis of breast cancer Read More »

Admit therapeutics receives accreditation from college of american pathologists

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved

Admit therapeutics receives accreditation from college of american pathologists Read More »

The 9th edition of IDIBELL’s PhD Day is held, this year focused on artificial intelligence

200 researchers and teaching staff have attended the ninth edition of the PhD Day, organized annually by the Committee of Predoctoral Researchers in collaboration with other IDIBELL units. This year’s conference focused on the use of artificial intelligence in research, with a workshop and a round table on the subject.

The 9th edition of IDIBELL’s PhD Day is held, this year focused on artificial intelligence Read More »

Scroll to Top